Halozyme Therapeutics shares owned by Macquarie Group
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Macquarie Group
from 13F filings
Historical chart of Macquarie Group investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Macquarie Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Macquarie Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $113M | 1.5M | 73.34 |
| 2025-06-30 | $108M | 2.1M | 52.02 |
| 2025-03-31 | $171M | 2.7M | 63.81 |
| 2024-12-31 | $139M | 2.9M | 47.81 |
| 2024-09-30 | $172M | 3.0M | 57.24 |
| 2024-06-30 | $161M | 3.1M | 52.36 |
| 2024-03-31 | $122M | 3.0M | 40.68 |
| 2023-12-31 | $121M | 3.3M | 36.96 |
| 2023-09-30 | $132M | 3.4M | 38.20 |
| 2023-06-30 | $119M | 3.3M | 36.07 |
| 2023-03-31 | $122M | 3.2M | 38.19 |
| 2022-12-31 | $148M | 2.6M | 56.90 |
| 2022-09-30 | $101M | 2.6M | 39.54 |
| 2022-06-30 | $111M | 2.5M | 44.00 |
| 2022-03-31 | $99M | 2.5M | 39.87 |
| 2021-12-31 | $124M | 3.1M | 40.28 |
| 2021-09-30 | $122M | 3.0M | 40.69 |
| 2021-06-30 | $133M | 2.9M | 45.21 |
| 2021-03-31 | $92M | 2.2M | 41.73 |
| 2020-12-31 | $99M | 2.3M | 42.70 |
| 2020-09-30 | $56M | 2.1M | 26.22 |
| 2020-06-30 | $6.3M | 236k | 26.73 |
| 2020-03-31 | $4.2M | 235k | 17.97 |
| 2019-12-31 | $4.1M | 230k | 17.73 |
| 2019-09-30 | $3.6M | 230k | 15.51 |
| 2019-06-30 | $4.0M | 230k | 17.18 |
| 2019-03-31 | $6.4M | 400k | 16.10 |
| 2018-12-31 | $7.3M | 500k | 14.63 |
| 2018-09-30 | $9.1M | 500k | 18.17 |
| 2018-06-30 | $8.4M | 500k | 16.87 |
| 2018-03-31 | $9.8M | 500k | 19.59 |
| 2017-12-31 | $10M | 504k | 20.26 |
| 2017-09-30 | $8.7M | 500k | 17.37 |
| 2017-06-30 | $6.4M | 500k | 12.82 |
| 2017-03-31 | $6.0M | 460k | 12.96 |
| 2016-12-31 | $4.5M | 460k | 9.88 |
| 2016-09-30 | $3.7M | 305k | 12.08 |
| 2016-06-30 | $2.6M | 305k | 8.63 |
| 2016-03-31 | $2.9M | 305k | 9.47 |